EC5026
EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators. EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids. Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators. sEH inhibitors developed by EicOsis have already shown efficacy for treating pain with no apparent adverse or addictive effects in laboratory animals and relieving naturally occurring pain in dogs, cats and horses.
Product Specifications
CAS Number
1809885-32-2
Product Name Alternative
BPN-19186
Purity
>98% (HPLC)
Solubility
DMSO:250 mg/mL (616.69 mM)
Smiles
O=C (NC1CCN (C ([C@@H] (C) CC) =O) CC1) NC2=CC=C (OC (F) (F) F) C (F) =C2
Molecular Formula
C18H23F4N3O3
Molecular Weight
405.39
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
4-Fluoro-3,5-dimethylphenylboronic Acid Pinacol Ester
4-Fluoro-3,5-dimethylphenylboronic Acid Pinacol Ester
PAK5 (p21 Activated Kinase 5, p21-activated Kinase 5, PAK5, PAK-5, KIAA1264, MGC26232, p21(CDKN1A)-activated Kinase 7, p21-activated Kinase 7, PAK7, PAK-7, Protein Kinase PAK5, Serine/threonine-protein Kinase PAK 7) (MaxLight 550)